待处理
入排:排除
图源:待检查
入排置信度 0.99
Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy.
Hang Quach, Ajay Nooka, Olga Samoylova, Christopher P Venner, Kihyun Kim, Thierry Facon, Andrew Spencer, Saad Z Usmani, Sebastian Grosicki, Kenshi Suzuki, Sosana Delimpasi, Katja Weisel, Mihaela Obreja, Anita Zahlten-Kumeli, Maria-Victoria Mateos
Br J Haematol 194(4) 784-788
入排依据:记录类型属于综述、Meta 分析、社论、评论、病例或指南。
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板